Hsiu-Ting Lin

Institute of Cellular and Organismic Biology, Academia Sinica — Taiwan

Medicine · Health Sciences

13h-index526citations22works5.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(16), Viral gastroenteritis research and epidemiology(7), SARS-CoV-2 detection and testing(7), Animal Virus Infections Studies(6), Monoclonal and Polyclonal Antibodies Research(5)

Publications22 total

Enhanced immunogenicity of an mRNA vaccine against dengue virus serotype 2 with modified key residue
Vaccine·2025· 3 cited
Multivalent mRNA Vaccine Elicits Broad Protection against SARS-CoV-2 Variants of Concern
Vaccines·2024· 7 citedOpen Access
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Journal of Biomedical Science·2023· 9 citedOpen Access
Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice
Heliyon·2023· 12 citedOpen Access
Monoclonal antibodies against S2 subunit of spike protein exhibit broad reactivity toward SARS-CoV-2 variants
Journal of Biomedical Science·2022· 15 citedOpen Access
An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization
International Journal of Pharmaceutics·2022· 31 citedOpen Access
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
Journal of Biomedical Science·2022· 42 citedOpen Access
Patient-Derived Organoid Serves as a Platform for Personalized Chemotherapy in Advanced Colorectal Cancer Patients
Frontiers in Oncology·2022· 35 citedOpen Access
An Efficient Approach for SARS-CoV-2 Monoclonal Antibody Production via Modified mRNA-LNP Immunization
2022· 5 cited
Broadly neutralizing antibodies against Omicron variants of SARS-CoV-2 derived from mRNA-lipid nanoparticle-immunized mice
2022· 1 citedOpen Access
Omicron-specific mRNA vaccine induced potent neutralizing antibody against Omicron but not other SARS-CoV-2 variants
2022· 38 citedOpen Access
Broadly Neutralizing Antibodies Against Omicron Variants of SARS-CoV-2 Derived from mRNA-Lipid Nanoparticle-Immunized Mice
SSRN Electronic Journal·2022Open Access
Antibody cocktail effective against variants of SARS-CoV-2
Journal of Biomedical Science·2021· 21 citedOpen Access
Monoclonal Antibodies against Nucleocapsid Protein of SARS-CoV-2 Variants for Detection of COVID-19
International Journal of Molecular Sciences·2021· 22 citedOpen Access
Structure-guided antibody cocktail for prevention and treatment of COVID-19
PLoS Pathogens·2021· 27 citedOpen Access
Effect of SARS-CoV-2 B.1.1.7 mutations on spike protein structure and function
Nature Structural & Molecular Biology·2021· 167 cited
Identification of COVID-19 B-cell epitopes with phage-displayed peptide library
Journal of Biomedical Science·2021· 27 citedOpen Access
Impacts on the structure-function relationship of SARS-CoV-2 spike by B.1.1.7 mutations
2021· 13 cited
Differential Polarization of Tumor-Associated Macrophages/Microglia Drives the Aggressiveness of Gliomas
Research Square (Research Square)·2021Open Access
Functional assessment of glioma pathogenesis by in vivo multi-parametric magnetic resonance imaging and in vitro analyses
Scientific Reports·2016· 16 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Han‐Chung Wu(17), Chen Wy(15), Kang-Hao Liang(12), Monika Kumari(11), Mi‐Hua Tao(8), Fu‐Fei Hsu(7), Yu‐Chi Chou(6), Ruei‐Min Lu(6), Yi‐Ling Lin(5), Shih-Chieh Su(5), Feng-Yi Ke(5), Tzu‐Jing Yang(4), Pei‐Yu Yu(4), Shang‐Te Danny Hsu(4), Chao‐Min Cheng(4), Shih-Han Ko(4), Yuan‐Chih Chang(3), Cheng‐Pu Sun(3), Ping‐Yi Wu(3), Mei-Jung Wang(3)